Analytik Jena AG
Analytik Jena AG english
Analytik Jena corrects earnings outlook for fiscal year 2001/2002
Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
Analytik Jena corrects earnings outlook for fiscal year 2001/2002
CFO leaves company
Analytik Jena AG (SIN 521 350) has lowered its earnings forecast for fiscal year
2001/2002. Management now reckons with break-even earnings before interest and
taxes (EBIT) for the fiscal year ending September 30, 2002, after previously
forecasting an approximate EBIT figure of 1.7m euros.
Furthermore, the Analytik Jena AG supervisory board and executive board have
announced that, as of December 1, 2002, Mr. Melik Maallem is resigning as the
company’s financial director for personal reasons. Mr. Maallem will continue to
make himself available to the company in an advisory role. His responsibilities
will be carried out by the company’s CEO, Klaus Berka, until his successor can
be appointed.
The executive board of Analytik Jena AG will host a conference call today at
11:00am CET (Germany) time. To dial in please call: +49-6074-8648.
Contact:
Analytik Jena AG
Klaus Berka, CEO
Thomas Fritsche, Investor Relations
Konrad-Zuse-Str. 1
07745 Jena
Tel. +49 3641 77-9281
Fax +49 3641 77-9149
ir@analytik-jena.de
http://www.analytik-jena.de
end of ad-hoc-announcement (c)DGAP 18.11.2002
Issuer’s information/explanatory remarks concerning this ad-hoc-announcement:
The chief reasons for the unforeseen earnings development, affecting the past
quarter most strongly, include unexpected valuation adjustments for the
company’s former business unit, “lab solutions”, which has now discontinued
operations. The unit’s had been slated for restructuring at the beginning of the
past fiscal year. Whereas the laboratory planning department of the former
business unit has now been fully integrated into AJZ Engineering, management has
decided to spin off its high-risk laboratory assembly service unit. In addition
to the costs associated with this, several of the unit’s projects could only be
completed with high losses, an unexpected development. The 2001/2002 annual
balance sheet will therefore be weighed down by unanticipated depreciation and
valuation adjustments.
Substantial costs, moreover, arose in connection with the incipient introduction
of the atom absorption spectrometer (AAS) in Japan and the newly opened “Middle
East” distribution office in Egypt; with these costs increasing particularly
over the last quarter. Especially the distribution and marketing activities
involving the introduction of the new equipment systems to the Japanese market
have proven unexpectedly cost-intensive. Management is, however, convinced of
the opportunities that are resulting from its market-opening work, with the
company strengthening its long-term international competitiveness by entering
the world’s second-largest market for AAS systems. The company’s strongly
accelerated increase in expenses for the expansion of its international
distribution network have already begun to be rewarded by a successful rise in
sales. Analytik Jena expects total revenue in the recently completed fiscal year
2001/2002 to have surpassed the 60m euros that had originally been planned.
——————————————————————————–
WKN: 521350; ISIN: DE0005213508; Index:
Listed: Neuer Markt in Frankfurt;
Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und
Stuttgart
180659 Nov 02
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden